First Tracks Biotherapeutics, Inc. · NASDAQ:TRAX

Affinity Asset Advisors, LLC reported a 5.80% stake in First Tracks Biotherapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 13, 2026

Affinity Asset Advisors, LLC reported a 5.80% stake in First Tracks Biotherapeutics, Inc., 2,032,012 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G).

Stake
5.80%
Shares
2,032,012
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Asset Advisors, LLC5.80%2,032,012
Michael Cho5.80%2,032,012

Source

View original at SEC

Related